Ctxr sec filings
WebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.
Ctxr sec filings
Did you know?
WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024
WebInstitutional Ownership and Shareholders Citius Pharmaceuticals Inc (US:CTXR) has 94 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). … WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024
WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio.
WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM …
WebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. on the poor side of town johnny riversWebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … on the populationWebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. on the popularity of sportsWebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to... ioptionsmonitor mockWebCitius Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 04/08/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider ... on the popularity of online celebrityWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024 on the popularity of online celebrity作文WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter ioption t